Long-circulating poly(ethylene glycol)-coated poly(lactid-co-glycolid) microcapsules as potential carriers for intravenously administered drugs

References

• Astete CE, Sabliov CM. Synthesis and characterization of PLGA nanoparticles. J Biomater Sci Polym Ed 2006; 17: 247–89
   PubMed Web of Science ®Google Scholar
• Avgoustakis K, Beletsi A, Panagi Z, Klepetsanis P, Karydas AG, Ithakissios DS. PLGA-mPEG nanoparticles of cisplatin: In vitro nanoparticle degradation, in vitro drug release and in vivo drug residence in blood properties. J Control Release 2002; 79: 123–35
   PubMed Web of Science ®Google Scholar
• Bala I, Hariharan S, Kumar MN. PLGA nanoparticles in drug delivery: The state of the art. Crit Rev Ther Drug Carrier Syst 2004; 21: 387–422
   PubMed Web of Science ®Google Scholar
• Bauer J, Zahres M, Zellermann A, Kirsch M, Petrat F, de Groot H, Mayer C. Perfluorocarbon-filled poly(lactide-co-gylcolide) nano- and microcapsules as artificial oxygen carriers for blood substitutes: A physico-chemical assessment. J Microencapsul 2010; 27: 122–32
   PubMed Web of Science ®Google Scholar
• Chang TM, Powanda D, Yu WP. Analysis of polyethylene-glycol-polylactide nano-dimension artificial red blood cells in maintaining systemic hemoglobin levels and prevention of methemoglobin formation. Artif Cells Blood Substit Immobil Biotechnol 2003; 31: 231–47
   PubMed Web of Science ®Google Scholar
• Cole DJ, Przybelski RJ, Schell RM, Martin RD. Diaspirin crosslinked hemoglobin (DCLHb) does not affect the anesthetic potency of isoflurane in rats. Artif Cells Blood Substit Immobil Biotechnol 1995; 23: 89–99
   PubMed Web of Science ®Google Scholar
• Council EPAE. European Commission (2010) Directive 2010/63/Eu on the protection of animals used for scientific purposes. Institute for Health and Consumer Protection, Ispra, Italy 2010
   Google Scholar
• Dalwadi G, Sunderland VB. Purification of PEGylated nanoparticles using tangential flow filtration (TFF). Drug Dev Ind Pharm 2007; 33: 1030–9
   PubMed Web of Science ®Google Scholar
• Dinarvand R, Sepehri N, Manoochehri S, Rouhani H, Atyabi F. Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents. Int J Nanomedicine 2011; 6: 877–95
   PubMed Web of Science ®Google Scholar
• Dunn SE, Coombes AGA, Garnett MC, Davis SS, Davies MC, Illum L. In vitro cell interaction and in vivo biodistribution of poly(lactide-co-glycolide) nanospheres surface modified by poloxamer and poloxamine copolymers. J Control Release 1997; 44: 65–76
   Web of Science ®Google Scholar
• Erhard J, Kirsch M, Bramey T, Petrat F, Mayer C, de Groot H. The first steps in redefining artificial oxygen carriers (AOC) for clinical use. Transfusion 2010; 50: 2517–18
   Web of Science ®Google Scholar
• Finder C, Wohlgemuth M, Mayer C. Analysis of particle size distribution by particle tracking. Particle & Particle Systems Characterization 2004; 21: 372–8
   Web of Science ®Google Scholar
• Finley JH. Spectrophotometric determination of polyvinyl alcohol in paper coatings. Anal Chem 1961; 33: 1925–7
   Web of Science ®Google Scholar
• Gref R, Domb A, Quellec P, Blunk T, Müller RH, Verbavatz JM, Langer R. The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres. Advanced Drug Delivery Reviews 1995; 16: 215–33
   PubMed Web of Science ®Google Scholar
• Gref R, Luck M, Quellec P, Marchand M, Dellacherie E, Harnisch S, Blunk T, Muller RH. ‘Stealth’ corona-core nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorption. Colloids Surf B Biointerfaces 2000; 18: 301–13
   PubMed Web of Science ®Google Scholar
• Gref R, Minamitake Y, Peracchia MT, Trubetskoy V, Torchilin V, Langer R. Biodegradable long-circulating polymeric nanospheres. Science 1994; 263: 1600–3
   PubMed Web of Science ®Google Scholar
• Gryparis EC, Hatziapostolou M, Papadimitriou E, Avgoustakis K. Anticancer activity of cisplatin-loaded PLGA-mPEG nanoparticles on LNCaP prostate cancer cells. Eur J Pharm Biopharm 2007; 67: 1–8
   PubMed Web of Science ®Google Scholar
• Harush-Frenkel O, Altschuler Y, Benita S. Nanoparticle-cell interactions: Drug delivery implications. Crit Rev Ther Drug Carrier Syst 2008; 25: 485–544
   PubMed Web of Science ®Google Scholar
• Kaneo Y, Hashihama S, Kakinoki A, Tanaka T, Nakano T, Ikeda Y. Pharmacokinetics and biodisposition of poly(vinyl alcohol) in rats and mice. Drug Metab Pharmacokinet 2005; 20: 435–42
   PubMedGoogle Scholar
• Kirsch M, Bramey T, Waack IN, Petrat F, Mayer C, De Groot H. The necessity of coating perfluordecalin-filled poly(lactide-co-glycolide) microcapsules in the presence of physiological cholate concentrations: Tetronic-908 as exemplary polymeric surfactant. J Microencapsul 2012; 29(1)30–8
   PubMed Web of Science ®Google Scholar
• Lee SC, Oh JT, Jang MH, Chung SI. Quantitative analysis of polyvinyl alcohol on the surface of poly(D, L-lactide-co-glycolide) microparticles prepared by solvent evaporation method: Effect of particle size and PVA concentration. J Control Release 1999; 59: 123–32
   PubMed Web of Science ®Google Scholar
• Li G, Stewart R, Conlan B, Gilbert A, Roeth P, Nair H. Purification of human immunoglobulin G: A new approach to plasma fractionation. Vox Sang 2002; 83: 332–8
   PubMed Web of Science ®Google Scholar
• Li M, Rouaud O, Poncelet D. Microencapsulation by solvent evaporation: State of the art for process engineering approaches. Int J Pharm 2008; 363: 26–39
   PubMed Web of Science ®Google Scholar
• Li Y, Pei Y, Zhang X, Gu Z, Zhou Z, Yuan W, Zhou J, Zhu J, Gao X. PEGylated PLGA nanoparticles as protein carriers: Synthesis, preparation and biodistribution in rats. J Control Release 2001; 71: 203–11
   PubMed Web of Science ®Google Scholar
• Lowe KC. Fluorinated blood substitutes and oxygen carriers. J Fluor Chem 2001; 109: 59–65
   Web of Science ®Google Scholar
• Makadia HK, Siegel SJ. Poly lactic-co-glycolic acid (PLGA) as biodegradable controlled drug delivery carrier. Polymers (Basel) 2011; 3: 1377–97
   PubMed Web of Science ®Google Scholar
• Mccarron PA, Marouf WM, Donnelly RF, Scott C. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality. J Biomed Mater Res A 2008; 87: 873–84
   PubMed Web of Science ®Google Scholar
• Mosqueira VC, Legrand P, Morgat JL, Vert M, Mysiakine E, Gref R, Devissaguet JP, Barratt G. Biodistribution of long-circulating PEG-grafted nanocapsules in mice: Effects of PEG chain length and density. Pharm Res 2001; 18: 1411–19
   PubMed Web of Science ®Google Scholar
• Mundargi RC, Babu VR, Rangaswamy V, Patel P, Aminabhavi TM. Nano/micro technologies for delivering macromolecular therapeutics using poly(D,L-lactide-co-glycolide) and its derivatives. J Control Release 2008; 125: 193–209
   PubMed Web of Science ®Google Scholar
• Nguyen KT, Shukla KP, Moctezuma M, Braden ARC, Zhou J, Hu Z, Tang L. Studies of the cellular uptake of hydrogel nanospheres and microspheres by phagocytes, vascular endothelial cells, and smooth muscle cells. J Biomed Mater Res A 2009; 88: 1022–30
   PubMedGoogle Scholar
• Panagi Z, Beletsi A, Evangelatos G, Livaniou E, Ithakissios DS, Avgoustakis K. Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. Int J Pharm 2001; 221: 143–52
   PubMed Web of Science ®Google Scholar
• Panyam J, Labhasetwar V. Biodegradable nanoparticles for drug and gene delivery to cells and tissue. Adv Drug Deliv Rev 2003; 55: 329–47
   PubMed Web of Science ®Google Scholar
• Paul A, Griffiths PC, James R, Willock DJ, Rogueda PG. Explaining the phase behaviour of the pharmaceutically relevant polymers poly(ethylene glycol) and poly(vinyl pyrrolidone) in semi-fluorinated liquids. J Pharm Pharmacol 2005; 57: 973–80
   PubMed Web of Science ®Google Scholar
• Peracchia MT, Harnisch S, Pinto-Alphandary H, Gulik A, Dedieu JC, Desmaele D, D'angelo J, Muller RH, Couvreur P. Visualization of in vitro protein-rejecting properties of PEGylated stealth polycyanoacrylate nanoparticles. Biomaterials 1999; 20: 1269–75
   PubMed Web of Science ®Google Scholar
• Pisal DS, Kosloski MP, Balu-Iyer SV. Delivery of therapeutic proteins. J Pharm Sci 2010; 99: 2557–75
   PubMed Web of Science ®Google Scholar
• Pisani E, Tsapis N, Paris J, Nicolas V, Cattel L, Fattal E. Polymeric nano/microcapsules of liquid perfluorocarbons for ultrasonic imaging: Physical characterization. Langmuir 2006; 22: 4397–402
   PubMed Web of Science ®Google Scholar
• Ratzinger G, Fillafer C, Kerleta V, Wirth M, Gabor F. The role of surface functionalization in the design of PLGA micro- and nanoparticles. Crit Rev Ther Drug Carrier Syst 2010; 27: 1–83
   Web of Science ®Google Scholar
• Redhead HM, Davis SS, Illum L. Drug delivery in poly(lactide-co-glycolide) nanoparticles surface modified with Poloxamer 407 and Poloxamine 908: In vitro characterisation and in vivo evaluation. J Control Release 2001; 70: 353–63
   PubMed Web of Science ®Google Scholar
• Sahoo SK, Panyam J, Prabha S, Labhasetwar V. Residual polyvinyl alcohol associated with poly(D,L-lactide-co-glycolide) nanoparticles affects their physical properties and cellular uptake. J Control Release 2002; 82: 105–14
   PubMed Web of Science ®Google Scholar
• Santander-Ortega MJ, Bastos-Gonzalez D, Ortega-Vinuesa JL. Electrophoretic mobility and colloidal stability of PLGA particles coated with IGG. Colloids Surf B Biointerfaces 2007; 60: 80–8
   PubMed Web of Science ®Google Scholar
• Santos-Magalhaes NS, Mosqueira VC. Nanotechnology applied to the treatment of malaria. Adv Drug Deliv Rev 2010; 62: 560–75
   PubMed Web of Science ®Google Scholar
• Shan X, Liu C, Yuan Y, Xu F, Tao X, Sheng Y, Zhou H. In vitro macrophage uptake and in vivo biodistribution of long-circulation nanoparticles with poly(ethylene-glycol)-modified PLA (BAB type) triblock copolymer. Colloids Surf B Biointerfaces 2009; 72: 303–11
   PubMed Web of Science ®Google Scholar
• Shelke NB, Rokhade AP, Aminabhavi TM. Preparation and evaluation of novel blend microspheres of poly(lactid-co-glycolic) acid and Pluronic F68/127 for controlled release of repaglinide. J Appl Polym Sci 2010; 116: 366–72
   Web of Science ®Google Scholar
• Shive MS, Anderson JM. Biodegradation and biocompatibility of PLA and PLGA microspheres. Adv Drug Deliv Rev 1997; 28: 5–24
   PubMed Web of Science ®Google Scholar
• Singh M, Kazzaz J, Ugozzoli M, Chesko J, O'hagan DT. Charged polylactide-co-glycolide microparticles as antigen delivery systems. Expert Opin Biol Ther 2004; 4: 483–91
   PubMed Web of Science ®Google Scholar
• Song X, Zhao X, Zhou Y, Li S, Ma Q. Pharmacokinetics and disposition of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) nanoparticles. Curr Drug Metab 2010; 11: 859–69
   PubMed Web of Science ®Google Scholar
• Stolnik S, Illum L, Davis SS. Long circulating microparticulate drug carriers. Advanced Drug Delivery Reviews 1995; 16: 195–214
   Web of Science ®Google Scholar
• Tabata Y, Ikada Y. Macrophage phagocytosis of biodegradable microspheres composed of L-lactic acid/glycolic acid homo- and copolymers. J Biomed Mater Res 1988; 22: 837–58
   PubMed Web of Science ®Google Scholar
• Tabata Y, Murakami Y, Ikada Y. Tumor accumulation of poly(vinyl alcohol) of different sizes after intravenous injection. J Control Release 1998; 50: 123–33
   PubMed Web of Science ®Google Scholar
• Tamilvanan S. Progress in design of biodegradable polymer-based microspheres for parenteral controlled delivery of therapeutic peptide/protein. Pharmaceutical manufacturing handbook: production and process, SC Gad. John Wiley & Sons, Inc, New York 2008; 393–441
   Google Scholar
• Thiele L, Diederichs JE, Reszka R, Merkle HP, Walter E. Competitive adsorption of serum proteins at microparticles affects phagocytosis by dendritic cells. Biomaterials 2003; 24: 1409–18
   PubMed Web of Science ®Google Scholar
• Van De Ven H, Paulussen C, Feijens PB, Matheeussen A, Rombaut P, Kayaert P, Van Den Mooter G, Weyenberg W, Cos P, Maes L, et al. PLGA nanoparticles and nanosuspensions with Amphotericin B: Potent in vitro and in vivo alternatives to Fungizone and AmBisome. J Control Release 2012; 161(3)795–803
   PubMed Web of Science ®Google Scholar
• Verrecchia T, Spenlehauer G, Bazile D, Murry-Brelier A, Archimbaud Y, Veillard M. Non-stealth (poly(lactic acid/albumin)) and stealth (poly(lactic acid-polyethylene glycol)) nanoparticles as injectable drug carriers. J Control Release 1995; 36: 49–61
   Web of Science ®Google Scholar
• Vonarbourg A, Passirani C, Saulnier P, Benoit JP. Parameters influencing the stealthiness of colloidal drug delivery systems. Biomaterials 2006; 27: 4356–73
   PubMed Web of Science ®Google Scholar
• Wischke C, Schwendeman SP. Principles of encapsulating hydrophobic drugs In PLA/PLGA microparticles. Int J Pharm 2008; 364: 298–327
   PubMed Web of Science ®Google Scholar
• Youan BB, Hussain A, Nguyen NT. Evaluation of sucrose esters as alternative surfactants in microencapsulation of proteins by the solvent evaporation method. AAPS Pharmsci 2003; 5: E22
   Google Scholar
• Zhao J, Liu CS, Yuan Y, Tao XY, Shan XQ, Sheng Y, Wu F. Preparation of hemoglobin-loaded nano-sized particles with porous structure as oxygen carriers. Biomaterials 2007; 28: 1414–22
   PubMed Web of Science ®Google Scholar